Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

VanEck Biotech ETF (BBH) Short Interest Ratio & Short Volume

VanEck Biotech ETF logo
$166.85 +1.81 (+1.10%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$166.85 0.00 (0.00%)
As of 08/15/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

VanEck Biotech ETF Short Interest Data

VanEck Biotech ETF (BBH) has a short interest of 3,500 shares, representing 0.17% of the float (the number of shares available for trading by the public). This marks a -37.50% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 7,747 shares to cover all short positions.

Current Short Interest
3,500 shares
Previous Short Interest
5,600 shares
Change Vs. Previous Month
-37.50%
Dollar Volume Sold Short
$567.14 thousand
Short Interest Ratio
0.4 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
2,110,000 shares
Short Percent of Float
0.17%
Today's Trading Volume
5,689 shares
Average Trading Volume
7,747 shares
Today's Volume Vs. Average
73%
Short Selling VanEck Biotech ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for VanEck Biotech ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BBH Short Interest Over Time

BBH Days to Cover Over Time

BBH Percentage of Float Shorted Over Time

VanEck Biotech ETF Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20253,500 shares $567.14 thousand -37.5%0.2%0.4 $162.04
7/15/20255,600 shares $872.76 thousand +47.4%N/A0.5 $155.85
6/30/20253,800 shares $582.46 thousand -32.1%0.2%0.3 $153.28
6/15/20255,600 shares $869.79 thousand -30.9%0.3%0.4 $155.32
5/31/20258,100 shares $1.20 million +22.7%0.4%0.6 $148.60
5/15/20256,600 shares $946.31 thousand +10.0%0.3%0.5 $143.38
4/30/20256,000 shares $915.60 thousand -46.4%N/A0.5 $152.60
4/15/202511,200 shares $1.65 million +761.5%0.5%1 $147.74
3/31/20251,300 shares $204.54 thousand -58.1%0.1%0.1 $157.34
3/15/20253,100 shares $504.25 thousand -73.3%0.1%0.3 $162.66
2/28/202511,600 shares $1.91 million +427.3%0.5%1.1 $164.58
2/15/20252,200 shares $353.23 thousand -24.1%0.1%0.2 $160.56
1/31/20252,900 shares $479.23 thousand +107.1%N/A0.3 $165.25
1/15/20251,400 shares $223.26 thousand -17.7%N/A0.1 $159.47
12/31/20241,700 shares $266.85 thousand +112.5%N/A0.2 $156.97
12/15/2024800 shares $130.74 thousand -96.4%N/A0.1 $163.42
11/30/202422,500 shares $3.77 million +2,712.5%N/A3.7 $167.37
11/15/2024800 shares $126.33 thousand +33.3%N/A0.2 $157.91
10/31/2024600 shares $101.78 thousand -45.5%N/A0.1 $169.63
10/15/20241,100 shares $196.07 thousand +57.1%N/A0.2 $178.25
9/30/2024700 shares $124.17 thousand +75.0%N/A0.1 $177.39
9/15/2024400 shares $72.48 thousand -55.6%N/A0.1 $181.20
8/31/2024900 shares $163.02 thousand -84.2%N/A0.1 $181.13
8/15/20245,700 shares $1.02 million +58.3%N/A0.9 $179.18
7/31/20243,600 shares $649.33 thousand -5.3%N/A0.6 $180.37
7/15/20243,800 shares $669.67 thousand -57.8%N/A0.6 $176.23
6/30/20249,000 shares $1.52 million -23.7%N/A1.3 $168.41
6/15/202411,800 shares $1.97 million +521.1%N/A1.5 $166.85
5/31/20241,900 shares $312.72 thousand -34.5%N/A0.3 $164.59
5/15/20242,900 shares $489.09 thousand +38.1%N/A0.4 $168.65
4/30/20242,100 shares $327.68 thousand -16.0%N/A0.3 $156.04
4/15/20242,500 shares $387.80 thousand -68.0%N/A0.3 $155.12
3/31/20247,800 shares $1.30 million +212.0%N/A0.9 $166.33
3/15/20242,500 shares $407.95 thousand +25.0%N/A0.3 $163.18
2/29/20242,000 shares $325.48 thousand +185.7%N/A0.2 $162.74
2/15/2024700 shares $114.42 thousand -22.2%N/A0.1 $163.46
1/31/2024900 shares $148.95 thousand -87.3%N/A0.1 $165.50
1/15/20247,100 shares $1.20 million +97.2%N/A0.5 $168.38
12/31/20233,600 shares $595.12 thousand -62.5%N/A0.3 $165.31
12/15/20239,600 shares $1.56 million -43.2%N/A0.8 $162.42
America’s Finest Hour: Sept 30 (Ad)

After This White House Deadline, All Bets Are Off The White House just issued a sweeping order that could send U.S.-based AI stocks soaring. But there's a catch – this mandate comes with a strict September 30th deadline for federal agencies to comply. If you don't act before that, you could miss out on the biggest returns. One of Wall Street's most brilliant investment millionaires explains why in a new FREE video.

Click here to see it.
11/30/202316,900 shares $2.56 million +122.4%N/A1.8 $151.70
11/15/20237,600 shares $1.14 million +7.0%N/A1 $150.53
10/31/20237,100 shares $1.03 million -17.4%N/A1 $144.38
10/15/20238,600 shares $1.35 million +53.6%N/A1.2 $156.83
9/30/20235,600 shares $872.09 thousand No ChangeN/A0.9 $155.73
9/15/20235,600 shares $897.34 thousand -9.7%N/A0.8 $160.24
8/31/20236,200 shares $1.01 million +82.4%N/A1 $163.61
8/15/20233,400 shares $551.82 thousand +70.0%N/A0.5 $162.30
7/31/20232,000 shares $321.56 thousand -23.1%N/A0.3 $160.78
7/15/20232,600 shares $409.29 thousand +8.3%N/A0.4 $157.42
6/30/20232,400 shares $374.52 thousand -7.7%N/A0.4 $156.05
6/15/20232,600 shares $420.39 thousand -13.3%N/A0.4 $161.69
5/31/20233,000 shares $463.89 thousand No ChangeN/A0.4 $154.63
5/15/20233,000 shares $483.96 thousand -52.4%N/A0.4 $161.32
4/30/20236,300 shares $1.01 million +14.6%N/A0.7 $159.73
4/15/20235,500 shares $913.17 thousand +22.2%N/A0.5 $166.03
3/31/20234,500 shares $729.41 thousand +95.7%N/A0.4 $162.09
3/15/20232,300 shares $360.48 thousand +4.6%N/A0.2 $156.73
2/28/20232,200 shares $343.84 thousand -74.1%N/A0.2 $156.29
2/15/20238,500 shares $1.40 million -38.0%N/A0.7 $164.77
1/31/202313,700 shares $2.30 million -38.6%N/A1 $167.74
1/15/202322,300 shares $3.75 million -9.0%N/A1.6 $168.27
12/30/202224,500 shares $3.91 million -9.9%N/A1.9 $159.74
12/15/202227,200 shares $4.51 million +115.9%N/A2 $165.75
11/30/202212,600 shares $2.12 million +106.6%N/A1 $168.16
11/15/20226,100 shares $1.02 million -80.7%N/A0.5 $166.95
10/31/202231,600 shares $4.97 million +182.1%N/A2.4 $157.23
10/15/202211,200 shares $1.63 million No ChangeN/A0.8 $145.46
9/30/20227,500 shares $1.06 million -33.6%N/A0.5 $140.78
9/15/202211,300 shares $1.67 million +41.3%N/A0.7 $147.60
8/31/20228,000 shares $1.17 million -7.0%N/A0.4 $145.98
8/15/20228,600 shares $1.41 million -1.2%N/A0.4 $163.51
7/31/20228,700 shares $1.34 million -44.9%N/A0.3 $154.31
7/15/202215,800 shares $2.41 million -63.3%N/A0.6 $152.63
6/30/202243,100 shares $6.28 million +698.2%N/A1.7 $145.79
6/15/20225,400 shares $734.29 thousand +12.5%N/A0.2 $135.98
5/31/20224,800 shares $710.35 thousand -61.9%N/A0.2 $147.99
5/15/202212,600 shares $1.80 million -4.6%N/A0.6 $143.14
4/30/202213,200 shares $1.93 million -2.9%N/A0.6 $146.38
4/15/202213,600 shares $2.24 million +18.3%N/A0.6 $164.50
3/31/202211,500 shares $1.86 million -24.3%N/A0.5 $162.13
3/15/202215,200 shares $2.27 million -20.8%N/A0.6 $149.67
2/28/202219,200 shares $3.02 million -27.6%N/A0.7 $157.06
2/15/202226,500 shares $4.24 million -9.6%N/A1 $160.10
1/31/202229,300 shares $4.83 million +67.4%N/A1.2 $164.90
1/15/202217,500 shares $3.04 million -10.7%N/A0.8 $173.62
12/31/202119,600 shares $3.71 million +67.5%N/A1 $189.34
12/15/202111,700 shares $2.24 million -44.0%N/A0.6 $191.44
11/30/202120,900 shares $4.09 million -4.1%N/A1.2 $195.79
11/15/202121,800 shares $4.15 million +28.2%N/A1.4 $190.45
America’s Finest Hour: Sept 30 (Ad)

After This White House Deadline, All Bets Are Off The White House just issued a sweeping order that could send U.S.-based AI stocks soaring. But there's a catch – this mandate comes with a strict September 30th deadline for federal agencies to comply. If you don't act before that, you could miss out on the biggest returns. One of Wall Street's most brilliant investment millionaires explains why in a new FREE video.

Click here to see it.
10/29/202117,000 shares $3.39 million -8.1%N/A1.1 $199.50
10/15/202118,500 shares $3.60 million -36.6%N/A1.2 $194.82
9/30/202129,200 shares $5.90 million +9.4%N/A1.8 $202.14
9/15/202126,700 shares $5.75 million -11.6%N/A1.8 $215.28
8/31/202130,200 shares $6.53 million -7.7%N/A2 $216.12
8/13/202132,700 shares $6.93 million +144.0%N/A2 $212.07
7/30/202113,400 shares $2.77 million -0.7%N/A0.8 $206.99
7/15/202113,500 shares $2.65 million -20.6%N/A0.9 $196.29
6/30/202117,000 shares $3.43 million -18.7%N/A1.2 $201.67
6/15/202120,900 shares $4.07 million -21.4%N/A1.5 $194.51
5/28/202126,600 shares $4.90 million +33.0%N/A2.3 $184.15
5/14/202120,000 shares $3.47 million +7.5%N/A1.8 $173.72
4/30/202118,600 shares $3.49 million +47.6%N/A1.5 $187.70
4/15/202112,600 shares $2.27 million -8.0%N/A1 $180.28
3/31/202113,700 shares $2.34 million +12.3%N/A1.1 $170.72
3/15/202112,200 shares $2.12 million -15.3%N/A0.9 $174.02
2/26/202114,400 shares $2.57 million -28.7%N/A1 $178.53
2/12/202120,200 shares $3.88 million +59.1%N/A1.2 $191.95
1/29/202112,700 shares $2.32 million -41.7%N/A0.7 $182.68
1/15/202121,800 shares $3.92 million +7.9%N/A1.3 $180.01
12/31/202020,200 shares $3.43 million -8.6%N/A1.2 $169.82
12/15/202022,100 shares $3.86 million -40.6%N/A1.3 $174.74
11/30/202037,200 shares $6.14 million -7.9%N/A2.1 $165.02
11/15/202040,400 shares $6.57 million +12.9%N/A2.2 $162.67
10/30/202035,800 shares $5.59 million -2.2%N/A1.9 $156.14
10/15/202036,600 shares $6.10 million -22.5%N/A0 $166.68
9/30/202047,200 shares $7.65 million -43.6%N/A2 $162.08
9/15/202045,100 shares $7.19 million -46.1%N/A1.6 $159.42
8/31/202083,700 shares $13.43 million -1.0%N/A2.8 $160.45

BBH Short Interest - Frequently Asked Questions

What is VanEck Biotech ETF's current short interest?

Short interest is the volume of VanEck Biotech ETF shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 3,500 shares of BBH short. 0.17% of VanEck Biotech ETF's shares are currently sold short. Learn More on VanEck Biotech ETF's current short interest.

Which institutional investors are shorting VanEck Biotech ETF?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of VanEck Biotech ETF: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for VanEck Biotech ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of VanEck Biotech ETF's floating shares are currently sold short.

Is VanEck Biotech ETF's short interest increasing or decreasing?

VanEck Biotech ETF saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 3,500 shares, a decline of 37.5% from the previous total of 5,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does VanEck Biotech ETF's short interest compare to its competitors?

0.17% of VanEck Biotech ETF's shares are currently sold short. Here is how the short interest of companies compare to VanEck Biotech ETF: VanEck Pharmaceutical ETF (41.19%), Invesco Dorsey Wright Healthcare Momentum ETF (0.26%), ProShares Ultra Nasdaq Biotechnology (0.88%), Invesco Nasdaq Biotechnology ETF (0.57%), First Trust Nasdaq Pharmaceuticals ETF (0.02%), JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (7.47%), and iShares Biotechnology ETF (29.39%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short VanEck Biotech ETF stock?

Short selling BBH is an investing strategy that aims to generate trading profit from VanEck Biotech ETF as its price is falling. BBH shares are trading up $1.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against VanEck Biotech ETF?

A short squeeze for VanEck Biotech ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BBH, which in turn drives the price of the stock up even further.

How often is VanEck Biotech ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBH, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:BBH) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsored
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...
Paradigm Press | Sponsored
Trump's New Plan to “Make China Pay”
Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...
Stansberry Research | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored